Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74117755)
Watch
English
Treatment of Alzheimer's disease
scientific article published on 01 January 2001
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Treatment of Alzheimer's disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
main subject
Alzheimer's disease
1 reference
based on heuristic
inferred from title
author name string
J L Cummings
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
publication date
1 January 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
published in
Clinical cornerstone
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
volume
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
page(s)
27-39
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
cites work
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-inflammatory drugs protect against Alzheimer disease at low doses.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of donepezil in Alzheimer's disease - results from a multinational trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholinesterase inhibitors: A new class of psychotropic compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospects for pharmacological intervention in Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of donepezil for vascular dementia: preliminary clinical experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1098-3597%2801%2990046-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1098-3597(01)90046-8
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
PubMed ID
11432120
1 reference
stated in
Europe PubMed Central
PubMed ID
11432120
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11432120%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit